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The short-term beneficial effects of physical rehabilitation programmes after cancer treatment have been described. However, little is
known regarding the long-term effects. The purpose of this study was to investigate the long-term effects of high-intensity resistance
training compared with traditional recovery. A total of 68 cancer survivors who completed an 18-week resistance training
programme were followed for 1 year. During the 1-year follow-up, 19 patients dropped out (14 due to recurrence of cancer). The
remaining 49 patients of the intervention group were compared with a group of 22 patients treated with chemotherapy in the same
period but not participating in any rehabilitation programme. Outcome measures were muscle strength, cardiopulmonary function,
fatigue, and health-related quality of life. One year after completion of the rehabilitation programme, the outcome measures in the
intervention group were still at the same level as immediately after rehabilitation. Muscle strength at 1 year was significantly higher in
patients who completed the resistance training programme than in the comparison group. High-intensity resistance training has
persistent effects on muscle strength, cardiopulmonary function, quality of life, and fatigue. Rehabilitation programmes for patients
treated with chemotherapy with a curative intention should include high-intensity resistance training in their programme.
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Oncologists and scientists have made substantial progress in
cancer treatment in the last few decades. Currently, the average
5-year survival rate is approaching 60% for female and 46% for
male patients (Signaleringscommissie Kanker, 2004). Between 2000
and 2015 the number of cancer survivors in the Netherlands is
expected to double. Not only improved medical treatment but also
greying of the population and a longer life expectancy are
contributing to increased cancer prevalence worldwide. As both
the number of cancer survivors and the length of their survival are
increasing, long-term health issues related to cancer and its
treatment are becoming more important (Demark-Wahnefried
et al, 2005; Ganz, 2005).
Cancer treatment is associated with substantial psychosocial and
physical side effects, including muscular atrophy, weight changes,
decreased resistance, depression, fatigue, and an overall decrease
in quality of life (Berglund et al, 1991; Dimeo et al, 1997, 2004;
Courneya and Friedenreich, 1999; Courneya, 2003; Wagner and
Cella, 2004). Furthermore, cancer survivors are at increased risk
for cancer recurrence and for secondary effects, such as
cardiovascular disease, diabetes, obesity, osteoporosis, and func-
tional decline (Demark-Wahnefried et al, 2005). In several cross-
sectional and intervention studies in healthy populations and in
patients with chronic diseases, regular physical activity is
associated with enhanced health and reduced risk of all-cause
mortality (Blair et al, 1995, 1996; Roberts and Barnard, 2005;
Lindstrom et al, 2006).
Rehabilitation programmes are currently being incorporated
more and more in the care of cancer patients as well (Lucia et al,
2003; Galvao and Newton, 2005; Knols et al, 2005). Systematic
review evidence shows that exercise in cancer survivors improves
quality of life, cardiorespiratory fitness, physical functioning, and
fatigue (Stevinson et al, 2004; Galvao and Newton, 2005; Knols
et al, 2005; McNeely et al, 2006). However, several intervention
studies incorporated in these reviews have some shortcomings.
First, most rehabilitation programmes are relatively short in
duration (less than 12 weeks) (Irwin and Ainsworth, 2004).
Second, in these programmes, patients were not stimulated to
remain physically active after the programme. Finally, most studies
use aerobic exercises such as walking or stationary cycling (Irwin
and Ainsworth, 2004). Few studies incorporated resistance training
in their programmes. A recent systematic review by Cheema et al
(2007) located only 10 trials that used progressive resistance
training in breast cancer patients. However, even this limited
number of studies indicates that resistance training has a great
potential to counteract side effects of cancer, such as muscle
wasting, reduced bone mineral density, and fatigue (Cunningham
et al, 1986; Ferrando et al, 1997; Twiss et al, 2001; Segal et al, 2003;
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As cancer rehabilitation is a relatively new area of research,
published studies mainly report the short-term effects of exercise
training. This is a major drawback, as physical and psychological
impairment may persist for many years after cancer treatment
(Berglund et al, 1991; Dimeo, 2001). Only four training studies in
cancer patients reported data of long-term follow-up. Two of them
involved a home-based training programme and one study used
only questionnaires to follow up the patients (Berglund et al, 1994;
Carlson et al, 2006; Demark-Wahnefried et al, 2006; Thorsen et al,
2007). The fourth study examined the effects of supervised training
after allogeneic stem cell transplantation (Carlson et al, 2006).
Our study investigated the long-term effects of high-intensity
resistance training on muscle strength, cardiopulmonary function,
fatigue, and quality of life in a more general population of cancer
patients after chemotherapy. To distinguish the observed long-
term effects from spontaneous recovery, a comparison was
performed with a similar group of patients who did not participate
in a rehabilitation programme. We hypothesised that cancer
patients benefit from high-intensity resistance training in terms of
muscle strength, cardiopulmonary function, fatigue, and quality of
life immediately after rehabilitation and 1 year after completing the
rehabilitation programme.
METHODS
Study design and patient selection
This study was conducted in two teaching hospitals, Ma ´xima
Medical Centre, Eindhoven (hospital 1) and Ma ´xima Medical
Centre, Veldhoven (hospital 2). The project was approved by the
Ethical Review Committee of the Ma ´xima Medical Centre, and
informed consent was obtained from all patients. Eligibility criteria
included histologically confirmed cancer with no indication of
recurrent or progressive disease, age between 25 and 70 years,
chemotherapy with curative intention administered between
January 2001 and December 2003, and completion of surgical
treatment or radiotherapy. Patients suffering from other serious
diseases that might hamper physical performance capacity, for
example, heart failure, COPD, and neurological disorders, were
excluded.
From 2001 onwards, rehabilitation using a high-intensity
resistance training programme was implemented as standard
medical care after chemotherapy in hospital 2. Medical oncologists
recruited all eligible patients treated with chemotherapy with a
curative intention. These patients were assigned to the intervention
group and were prospectively followed from the start of the
rehabilitation programme up to 12 months after completing the
programme. The comparison group, treated in hospital 1, was a
similar group of cancer patients who underwent chemotherapy in
the same period as the intervention group. This group of patients
was not offered any exercise or rehabilitation programme. The
same inclusion and exclusion criteria were applied as in the
intervention group. The oncologists and the patients in hospital 1
were not aware of the benefit of the rehabilitation programme in
hospital 2 in 2001 and 2002. Figure 1 shows the flowchart of the
study and the patient selection. One year after completion of the
training programme, 49 consecutive patients were included in the
follow-up. Twenty-two patients were included in the comparison
group. These patients did not exercise under supervision. There
was no further information from these patients about their activity
level. The characteristics of these patients are shown in Table 1.
Chemotherapy in 
2001–2002 in hospital 1
Long-term test
(22 patients)
18 weeks
TRAINING PROGRAMME
(68 patients)
Week 22 test
Week 34 test
Week 30 test
Week 26 test
1 dropout: recurrence (1)
0 dropouts
4 dropouts: recurrence (3),
co-morbidity (1)
7 dropouts: recurrence (5),
personal reasons (2)
Week 68 test 
(49 patients)
27 eligible patients 
were contacted
5 dropouts: 
moved house (2), 
not interested (3)
Chemotherapy in 
2001–2003 in hospital 2
7 dropouts: recurrence (5),
personal reasons (2)
Week 0 test
Week 18 test
Figure 1 Flow chart of the study.
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The 18-week training programme consisted of high-intensity
resistance and interval training. To counteract bias resulting from
spontaneous recovery after chemotherapy, training started not
earlier than 6 weeks after completing chemotherapy. The patients
trained in groups of six to eight persons on specialised resistance
training equipment and on bicycle ergometers under the super-
vision of physical therapists. During the first 12 weeks, patients
were trained twice a week. In the last six weeks, patients were
trained once a week.
High-intensity resistance training The resistance programme
consisted of six exercises targeting the large muscle groups as
follows: (1) vertical row (focusing on longissimus, biceps brachii,
rhomboideus); (2) leg press (quadriceps, glutei, gastrocnemius);
(3) bench press (pectoralis major, triceps); (4) pull over
(pectoralis, triceps brachii, deltoideus, trapezius); (5) abdominal
crunch (rectus abdominis); and (6) lunge (quadriceps, glutei,
hamstrings). First, resistance exercises were performed at 65–80%
of one-repetition maximum (1-RM) and consisted of two sets of 10
repetitions. After the 12th week, the emphasis shifted from muscle
strength to muscle endurance involving training with less
resistance (35–40% of 1-RM) but more (20) repetitions. Every 4
weeks the training progress was evaluated, and the result was
adjusted by means of a 1-RM test.
Interval training Interval training consisted of cycling two times
for 8min, before and after the resistance exercises. In the first 8
weeks, those 8min consisted of alternating 30s at 65% of the
maximal short exercise capacity (MSEC) and 60s at 30%. A steep
ramp test was performed to determine the MSEC. After 30s of
cycling at 25W, the load was increased by 25W every 10s until
exhaustion. From week 9, those 8min consisted of alternating 30s
at 65% and 30s at 30% of the MSEC. Results of the steep ramp test
were described in a previous publication (De Backer et al, 2007a).
Follow-up At the end of the rehabilitation programme (week 18),
patients were advised by a sports physician to continue physical
activity at home. These personalised advices were based on the
patient’s individual interests and motivation. In the follow-up
period, there were five appointments (week 22, 26, 30, 34, and 68)
with a physical therapist to encourage the patients to stay active
and to perform a muscle strength test. In week 68, cardiopulmon-
ary function, Multidimensional Fatigue Inventory (MFI), and
health-related quality of life (HRQOL) were reported along with
muscle strength.
Outcome measures
Muscle strength For the determination of muscle strength, the
indirect 1-RM test was used (Sale and MacDougall, 1981; Mayhew
et al, 1995). One-repetition maximum is the maximum amount of
weight that can be lifted once. Indirect 1-RM values were
calculated from the Brzycki’s equation (Sale and MacDougall,
1981; Mayhew et al, 1995). One-repetition maximum is stated in
kilograms in proportion to body weight. Muscle groups were tested
with the resistance equipment that was also used for the training
(leg press, vertical row, bench press, lunge, pull over, and
abdominal crunch). This test was performed seven times: at the
start (week 0) and the end of the programme (week 18) and in the
follow-up period (weeks 22, 26, 30, 34, and 68).
Cardiopulmonary function Cardiopulmonary function was as-
sessed by cardiopulmonary exercise testing, which was performed
on a cycle ergometer (Corival, Lode, The Netherlands). Expired
gases were collected and analysed breath by breath for O2,C O 2,
and volume. Electrocardiogram was continuously monitored.
Patients were instructed and encouraged to continue exercise
until exhaustion. The test was ended if patients were unable to
maintain the required pedalling frequency of 70r.p.m. At the end
of the test, peak oxygen consumption (peak VO2), peak power
output, and peak heart rate were registered. Ventilatory threshold
was determined by using the oxygen equivalent method
(Wasserman et al, 1999). In addition, cardiopulmonary exercise
testing was used to identify potential cardiopulmonary limitations
caused by cardiotoxic (e.g. anthracyclins) or pulmotoxic (e.g.
bleomycin) medications or by radiation therapy to the breast
(Dimeo, 2001; Winningham, 2001; Myers, 2005).
This test was performed before (week 0) and after the training
programme (week 18) and in week 68 according to the standard
Table 1 Patient characteristics of the intervention and comparison
groups
Intervention
group (n¼49)
Comparison
group (n¼22)
n % n %
Gender
Male 9 18 4 18
Female 40 82 18 82
Type of tumour
Breast 32 65 14 64
Ovarian 3 6 0 0
H L 4829
NHL 3 6 3 14
Colorectal 5 10 3 14
Testis 2 4 0 0
Treatment
Chemotherapy 49 100 22 100
+Radiotherapy 3 6 0 0
+Surgery 14 29 4 18
+Radiotherapy+surgery 28 57 17 77
Chemotherapy
AC, breast 14 29 9 41
CMF, breast 7 14 3 14
FEC, breast 11 22 2 9
Carboplatin–paclitaxel, ovarian 3 6 0 0
ABVD/EBVP/BEACOPP, HL 4 8 2 9
CHOP/CVP, NHL 3 6 3 14
5-FU leucovorin, colorectal 5 10 3 14
BEP, testis 2 4 0 0
Mean s.d. Mean s.d.
Age (years)
Mean 48 8 51 11
Anthropometry
Height (cm) 170 7 173 8
Weight (kg) 78 11 77 14
Time since last chemotherapy
Weeks between last
chemotherapy and test week 68
96 26 169 26
ABVD¼doxorubicin, bleomycin, vinblastine, dacarbazine; AC¼adriamycin, cyclo-
phosphamide; BEACOPP¼bleomycin, etoposide, doxorubicin, cyclophosphamide,
vincristine, procarbazine, prednisone; BEP¼bleomycin, etoposide, cisplatin;
CHOP¼cyclophosphamide, doxorubicin, vincristine, prednisone; CMF¼cyclopho-
sphamide, methotrexate, fluorouracil; CVP¼cyclophosphamide, vincristine, predni-
sone; EBVP¼epirubicin, bleomycin, vincristine, prednisone; FEC¼fluorouracil,
epirubicin, cyclophosphamide; HL¼Hodgkin’s lymphoma; NHL¼non-Hodgkin’s
lymphoma.
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Testing and European Respiratory Society, 1997).
Fatigue The MFI is a questionnaire consisting of 20 statements
for which the person has to indicate on a 7-point scale the extent to
which the particular statement applies to him or her. The
statement refers to aspects of fatigue experienced during the
previous few days. Higher scores indicate a higher degree of
fatigue. This self-report instrument consists of five subscales based
on different dimensions: general fatigue, physical fatigue, reduced
activity, reduced motivation, and mental fatigue. This question-
naire was completed in weeks 0, 18, and 68.
Health-related quality of life Quality of life was assessed using
the European Organisation for Research and Treatment of Cancer
Core Quality of Life Questionnaire C30 (EORTC QLQ-C30). This
questionnaire has a high reliability and validity (Aaronson et al,
1993; Groenvold et al, 1997). The EORTC QLQ-C30 encompasses
30 items divided into six functional scales (physical, role,
cognitive, emotional and social functioning, and global quality of
life), three symptom scales (fatigue, nausea, and pain), and six
individual items. This questionnaire was completed in weeks 0, 18,
and 68.
Statistical analyses
In the training group, dropouts and patients who continued the
study were analysed for differences in gender, age, cancer
diagnosis, time from last treatment, and initial muscle strength
by means of w
2 tests or independent samples t-tests.
w
2 Tests for categorical data and independent samples t-tests for
continuous data were used to examine group differences in terms
of gender, age, cancer diagnosis, time between completion of
treatment, and long-term outcome between the training group and
the comparison group.
A repeated measure analysis (SPSS mixed linear) was used to
assess differences in muscle strength between seven different time
points (weeks 0, 18, 22, 26, 30, 34, and 68). Post hoc Bonferroni
correction was used as a protection against Type I error.
Paired sample t-tests were used to test the significance of
changes in mean scores for cardiopulmonary function, fatigue, and
HRQOL from baseline (week 0) to post-intervention (week 18),
post-intervention to week 68, and week 0 to week 68. The last
measured values for the dropouts were used for the week 68 test
(intention-to-treat analysis).
Independent sample t-tests were used to analyse differences in
muscle strength, cardiopulmonary function, HRQOL, and fatigue
between the training group and the comparison group.
All statistical analyses were performed using the statistics
program SPSS (version 13.0).
RESULTS
Adherence and baseline characteristics
In the intervention group, 68 patients were monitored for 12
months after the rehabilitation programme. Fourteen patients were
excluded because of cancer recurrence, and one patient was
excluded because of serious co-morbidity. Four patients left during
the follow-up period for personal reasons and were considered
non-adherent dropouts, resulting in a dropout rate of 6%. Of the
27 patients who proved eligible to participate in the comparison
group, 22 took part in the exercise tests and completed the
questionnaires, resulting in a dropout rate of 23%. There were no
significant differences in gender, age, and cancer diagnosis
between the intervention and the comparison groups. Moreover,
there were no significant differences in gender, age, and cancer
diagnosis between the dropouts and those patients completing the
study. The time interval between last treatment and long-term test
was shorter in the training group than in the comparison group (96
vs 169 weeks, Po0.01).
Long-term effects on muscle strength and differences in
muscle strength between the training and the comparison
groups
Table 2 shows the test results at baseline, post-rehabilitation, and
after long-term follow-up (week 68) in the intervention group and
the comparison group. Muscle strength improved significantly
after training. Repeated measure analysis shows that the improve-
ment of muscle strength was maintained in the long term. There
were no significant differences between long-term measurements
and post-rehabilitation in all resistance exercises. Figure 2 shows
the progress in muscle strength in all exercises at seven different
time points. After 18 weeks of training, muscle strength stabilises
until week 68. All 1-RM test results were significantly higher in the
intervention group than in the comparison group for vertical row
(50%), leg press (33%), bench press (57%), pull over (100%), lunge
(119%), and abdominal crunch (37%).
Long-term effects on cardiopulmonary function and
differences between the training and the comparison
groups
Table 2 shows the data of cardiopulmonary outcomes. There was a
significant effect of training on the peak oxygen consumption
(þ12%), maximal workload (þ15%), peak heart rate (þ3%), and
ventilatory threshold (þ16%). This effect was maintained in the
long term, as shown by the fact that there were no significant
differences in cardiopulmonary function between week 18 and
week 68. Results of the comparison group were not significantly
different from those of the intervention group.
Long-term effects on fatigue and quality of life and
differences between the training and the comparison
groups
Table 2 shows the data of different subscales of fatigue (MFI) and
quality of life (HRQOL). All subscales of MFI, except for reduction
in motivation, improved significantly after training. The improve-
ment in the fatigue outcome measures persisted 1 year after
completing the training programme. However, in the long term,
there were no differences between the comparison group and the
intervention group in MFI. Health-related quality of life also
improved significantly post-treatment, and this effect continued in
the long term. There were no differences between the training
group and the comparison group on all subscales of HRQOL.
DISCUSSION
This is the first study that describes the long-term effects of a high-
intensity resistance training programme in cancer patients. The
tolerance and effects noted immediately post-rehabilitation have
already been published (De Backer et al, 2007b). After completion
of the programme, repeated testing showed a continuation and
stabilisation of the muscle strength level (Figure 2) and peak VO2.
Muscle strength was significantly higher in patients who completed
the resistance training programme than in the comparison group.
Questionnaire outcomes indicate an overall improvement imme-
diately after rehabilitation on several scales of quality of life and of
fatigue, especially physical fatigue. This improvement was also
maintained 1 year later. However, there were no differences in
quality of life, fatigue, and peak VO2 between the intervention and
the comparison groups.
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in the primary and secondary prevention of cancer (Stein and
Colditz, 2004; Holmes et al, 2005). Several randomised, controlled
trials have examined the short-time effects of physical activity after
the diagnosis of cancer. Overall, most studies demonstrated that
physical training programmes had beneficial effects on cancer
patients’ physical or psychosocial capacity and, as a consequence,
on their quality of life (Lucia et al, 2003; Knols et al, 2005). Despite
the mounting evidence of the significance of physical activity
after cancer treatment, there are presently only four studies that
have assessed the long-term effects of physical rehabilitation
programmes.
Two studies examined the long-term effect of a home-based
training programme (Demark-Wahnefried et al, 2006; Thorsen
et al, 2007). Demark-Wahnefried et al evaluated a 6-month home-
based diet and exercise programme (telephone counselling and
mailed materials) by telephone interview at 6 and 12 months after
the start. This study included only older breast and prostate cancer
patients (X65 years). In the long term (12 months), there were no
significant differences between the intervention and the compar-
ison groups in physical functioning, diet quality index, fatigue, and
energy expenditure as measured by telephone questionnaires
(Demark-Wahnefried et al, 2006). Thorsen et al recently published
their long-term data of a randomised study of a 3-month home-
based training programme. In contrast to our study, the favourable
effect on cardiopulmonary functioning could not be sustained
during a 12-month follow-up. The researchers concluded that for a
longer-lasting effect over time, a longer intervention period and
more intense exercise were needed (Thorsen et al, 2007). Another
possible explanation for the lack of long-term effects is the
supervised training used in our study rather than the home-based
training programmes used in the previous studies. The multiple
visits after the programme for testing may have contributed to the
persistent effect in our programme.
The third study that examined the long-term effects of training
in cancer patients is by Carlson et al. This study examined the
effects of supervised aerobic exercise training after 12 months in 12
patients after allogeneic haematopoietic stem cell transplantation.
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Figure 2 Muscle strength from start of rehabilitation up to 12 months
after completing rehabilitation.
Table 2 Effects of training on muscle strength, cardiopulmonary function, fatigue, and quality of life on different time points
Baseline (week 0) Post-rehabilitation (week 18)
Long-term (week 68)
Outcome measure Intervention group Intervention group Intervention group Comparison group
Muscle strength (1-RM/kg)
Vertical row 0.48 (0.16) 0.69 (0.20)
a 0.68 (0.20)
c 0.46 (0.11)
e
Leg press 1.96 (0.51) 2.79 (0.62)
a 2.89 (0.74)
c 2.20 (0.51)
e
Bench press 0.30 (0.11) 0.46 (0.15)
a 0.45 (0.15)
c 0.30 (0.11)
e
Pull over 0.12 (0.05) 0.25 (0.08)
a 0.26 (0.10)
c 0.13 (0.06)
e
Lunge 0.20 (0.09) 0.42 (0.17)
a 0.46 (0.16)
c 0.21 (0.10)
e
Abdominal crunch 0.39 (0.14) 0.60 (0.17)
a 0.64 (0.18)
c 0.46 (0.13)
e
Cardiopulmonary outcomes
Peak oxygen consumption (mlmin
 1kg
 1) 25.7 (6.3) 28.9 (6.7)
b 29.3 (8.4)
d 27.8 (5.6)
Peak power output (Wkg
 1) 2.0 (0.6) 2.3 (0.7)
b 2.5 (0.8)
d 2.2 (0.6)
Peak heart rate (beats per min) 167 (17) 172 (14)
b 168 (20)
d 165 (18)
Ventilatory threshold (mlmin
 1kg
 1) 19.2 (4.7) 22.3 (5.7)
b 23.5 (7.1)
d 22.2 (4.9)
MFI
General fatigue 13.1 (4.5) 9.2 (4.1)
b 9.9 (4.4)
d 10.6 (4.4)
Reduced activity 11.8 (4.4) 8.1 (3.4)
b 8.2 (3.8)
d 8.8 (4.3)
Mental fatigue 10.0 (4.4) 8.8 (3.8)
b 8.4 (4.0)
d 7.9 (4.2)
Physical fatigue 13.7 (4.1) 8.1 (3.5)b 9.2 (4.0)
d 9.9 (4.8)
Reduced motivation 8.7 (3.1) 7.7 (2.8) 7.8 (3.5) 8.4 (4.1)
HRQOL
Physical functioning 72.4 (19.2) 84.2 (19.0)
b 85.5 (18.5)
d 81.8 (18.4)
Role functioning 60.3 (24.0) 79.5 (21.1)
b 79.4 (22.5)
d 83.3 (20.6)
Emotional functioning 75.6 (20.2) 85.7 (18.8)
b 84.1 (18.4)
d 81.3 (20.7)
Cognitive functioning 76.5 (24.4) 83.8 (21.5) 85.6 (17.3)
d 82.6 (19.3)
Social functioning 68.4 (29.3) 82.5 (21.6)
b 82.3 (24.2)
d 84.1 (20.8)
Fatigue 43.6 (23.4) 22.0 (18.8)
b 24.8 (22.0)
d 29.8 (21.3)
HRQOL¼health-related quality of life; MFI¼multidimensional fatigue index; 1-RM¼one-repetition maximum. All data are means (s.d.).
aSignificant difference, Po0.01, baseline
and post-rehabilitation (repeated measure analyses).
bSignificant difference, Po0.01, baseline and post-rehabilitation (paired t-tests).
cSignificant difference, Po0.01, baseline and
week 68 (repeated measure analyses).
dSignificant difference, Po0.01, baseline and week 68 (paired t-tests).
eSignificant difference, Po0.01, the intervention and comparison
groups (independent sample t-tests).
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stroke volume were found (Carlson et al, 2006). The fourth study
of Berglund et al evaluated a training programme over a 1-year
follow-up period. The intervention group improved significantly
more than the comparison group in physical strength and physical
activity levels, both of which were evaluated by means of
questionnaires. In our study, the cardiopulmonary function and
muscle strength were assessed by exercise tests (peak VO2 and
1-RM), which are more valid and reliable outcome measures.
As cancer rehabilitation is a relatively new area of research,
there is no consensus about the optimal type of training in a
rehabilitation programme. Exercise interventions vary consider-
ably from brief instructions of home-based exercises to highly
structured, supervised exercise sessions on strength equipment
(Conn et al, 2006). It is remarkable that most studies only used
aerobic exercises such as walking or stationary cycling in their
rehabilitation programmes (Courneya et al, 2003), as one of the
side effects of cancer and its treatment is muscle atrophy (Argiles
et al, 2005). To improve muscle strength and increase muscle
mass, resistance training is more important than aerobic exercise.
Also, considerable evidence now suggests that the ability to
perform physical tasks in daily life is determined by a threshold
level of muscular resistance (Brill et al, 2000). As a consequence,
resistance training seems to be the programme of choice for
regaining muscle strength and, in this way, improving activities of
daily living and HRQOL (Brill et al, 2000). In addition, in cancer
patients, muscle strength is related to quality-of-life aspects with
correlations ranging from 0.47 to 0.75 (De Backer et al, 2007b).
The results of the questionnaires, HRQOL, and MFI, did not
differ between the two groups. A possible explanation for this is
the high outcome values in the questionnaires. It is most likely that
a ceiling effect is reached a rather long time after cancer treatment.
Cancer patients may be satisfied with their ‘survival status’ and
score high in all QOL questionnaires despite existing limitations
and complaints. This experience is familiar to other researchers
(van de Poll-Franse et al, 2006). Also, the significant difference in
time span since the last treatment between the two groups, in
favouring the comparison group, could be a reasonable explana-
tion. Although in our study the mean level of quality of life is high,
the large ranges for quality-of-life outcomes suggest that a
subgroup of survivors may report lower quality-of-life levels.
Our study design has some shortcomings. First, the different
time intervals between last treatment and long-term test for the
comparison group (169 weeks) and the training group (96 weeks).
However, we expect that this longer time span (if it has caused
bias) will be in favour of the comparison group because this group
has more time for spontaneous recovery after intensive treatment.
Second, the lack of baseline measurements in the comparison
group is a limitation of the current study. These shortcomings
could be overcome by a prospective, randomised, controlled
clinical trial. However, such a study design is not practical for
exercise intervention trials. First, patients cannot be blinded to
their treatment; only the outcome assessor can be blinded to group
allocation. Second, when patients are participating in a training
study and are randomised to the control or waiting group, they
start to get more active spontaneously. Particularly in a group of
cancer patients, subjects might come into contact with other
subjects. Finally, the short-term benefits of exercise are recognised
in research and clinics. It could be considered unethical to restrain
patients from an exercise-containing rehabilitation programme.
Therefore, we believe that our study design is appropriate in
cancer rehabilitation research, especially when long-term effects
are studied.
CONCLUSION
This is the first study that describes the long-term effects of a high-
intensity resistance training programme in cancer patients. Results
indicate that after a 12-month follow-up, the beneficial effects on
muscle strength, cardiopulmonary function, HRQOL, and fatigue
were sustained. Muscle strength was significantly higher in the
intervention group than in the comparison group. Based on these
results, we suggest that guidelines for rehabilitation in oncology
patients should include high-intensity resistance training.
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